A detailed history of Asset Dedication, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Asset Dedication, LLC holds 202 shares of VRTX stock, worth $91,095. This represents 0.01% of its overall portfolio holdings.

Number of Shares
202
Previous 202 -0.0%
Holding current value
$91,095
Previous $94,000 1.06%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$392.81 - $485.53 $39,281 - $48,553
100 Added 98.04%
202 $94,000
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $19,614 - $21,022
58 Added 131.82%
102 $35,000
Q1 2023

Apr 21, 2023

BUY
$283.23 - $323.1 $12,462 - $14,216
44 New
44 $14,000
Q4 2020

Jan 28, 2021

SELL
$207.01 - $276.09 $7,659 - $10,215
-37 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$255.65 - $303.1 $9,459 - $11,214
37 New
37 $10,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.